CIK 0001826457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Monte Rosa Therapeutics, Inc.
Sign in to watch- Ticker
- GLUE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2643
- Business address
- 321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
- Former names
- Monte Rosa Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy Director bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at $19.00 ($19,950,000)
- 4 Open-market buy Director bought 157,895 shares at $19.00 ($3,000,005)
- 4 Open-market buy 10% owner bought 157,895 shares at $19.00 ($3,000,005)
- 4 Open-market buy Former 10% Owner bought 600,000 shares at $19.00 ($11,400,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 9 · 171 filings